Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma

NCT06898970 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Angiosarcoma
Angiosarcoma, Adult

Interventions

BIOLOGICAL: Vusolimogene Oderparepvec (VO)
DRUG: Pembrolizumab

Sponsor

Varun Monga, MBBS

Collaborators

[object Object]